Sales and Marketing

Showing 15 posts of 11520 posts found.

Sankyo and Daiichi set to continue Japanese consolidation

February 24, 2005 Sales and Marketing

Two of Japan's leading pharmaceutical companies Sankyo and Daiichi look set to merge later this year, accelerating consolidation in the …

FDA panel clears Vioxx return to market

February 21, 2005 Sales and Marketing

An FDA panel has narrowly voted in favour of allowing Vioxx to return to the market, after concluding it carries …

IMS and Innovex announce UK alliance

February 17, 2005 Sales and Marketing

Pharma data consultants IMS have announced a new alliance with contract sales provider Innovex to supply its field forces with …

ADHD latest drugs to be hit by safety warnings

February 17, 2005 Sales and Marketing

Attention deficit hyperactivity disorder (ADHD) treatments are the latest class of drugs to be hit by safety warnings, with regulators …

New FDA drug safety board to be more independent

February 17, 2005 Sales and Marketing

A new independent FDA board will be set up to monitor drug safety and issue warnings to doctors and patients …

Roche hepatitis and HIV combination approved

February 9, 2005 Sales and Marketing

Roche's Pegasys has become the first treatment licensed for patients suffering hepatitis C and HIV at the same time.The European …

Sanofi-Aventis sponsor cardiovascular research centre

February 9, 2005 Sales and Marketing

A new UK centre specialising in research into cardiovascular disease has opened its doors at St Mary's Hospital in Paddington, …

Schering launches new dermatology company

February 8, 2005 Sales and Marketing

German pharma company Schering has created a new, independent group, Intendis, focused on developing and marketing dermatology products.Intendis' new management …

Rare side-effect warnings for Strattera

February 8, 2005 Sales and Marketing

UK health professionals have been warned  about rare but serious liver problems observed in Lilly's Strattera.The drug has been licensed …

New depression treatment launched in the UK

February 3, 2005 Sales and Marketing

Lilly and Boehringer Ingelheim's depression treatment Cymbalta has been launched in the UK where it will do battle in the …

New ‘economic damage’ offence to beat animal activists

February 3, 2005 Sales and Marketing

The government has unveiled new laws to counteract the intimidation tactics used by activists to undermine animal research. Animal rights …

‘Smarter steroid’ Alvesco launched in the UK

February 3, 2005 Sales and Marketing

Alvesco, the first one puff, once-daily inhaled corticosteroid for asthma has been launched in the UK, its first European market.Manufacturers …

Aspirin plus PPI better than Plavix in patients with GI bleed

February 2, 2005 Sales and Marketing

A new study has concluded that aspirin plus a proton pump inhibitor (PPI) is more effective than Plavix (clopidogrel) in …
The Gateway to Local Adoption Series

Latest content